Shankara Buildpro Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Shankara Buildpro Ltd is ₹ 175.5 as of 30 Oct 14:42 . The P/E Ratio of Shankara Buildpro Ltd changed from 18.1 on March 2026 to 18.1 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Shankara Buildpro Ltd changed from ₹ 2318 crore on March 2026 to ₹ 2318 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The revenue of Shankara Buildpro Ltd for the Jun '26 is ₹ 1890 crore as compare to the Mar '26 revenue of ₹ 1996 crore. This represent the decline of -5.33% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Shankara Buildpro Ltd for the Jun '26 is ₹ 61.58 crore as compare to the Mar '26 ebitda of ₹ 70.08 crore. This represent the decline of -12.13% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Shankara Buildpro Ltd changed from ₹ 16.63 crore to ₹ 35.78 crore over 9 quarters. This represents a CAGR of 40.57% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Shankara Buildpro Ltd changed from 9.51 % on March 2026 to 9.51 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Shankara Buildpro Ltd

Shankara Buildpro Limited was incorporated as 'Shankara Buildpro Private Limited' on October 13, 2023, as a wholly owned subsidiary of SBPL, in the state of Karnataka.
Further, pursuant to conversion of Company from private company into public company, the name of the Company was changed to 'Shankara Buildpro Limited' vide Certificate of Incorporation dated November 30, 2023.
The Company was incorporated with the primary focus on engaging in retailing, trading, warehousing, wholesale distribution and ecommerce activities related to all building materials. The Trading Business of erstwhile promoter SBPL got transferred into the Company as a going concern. pursuant to the Scheme of Arrangement for Demerger with effect from April 01, 2024, making it effective from 9th September 2025.
Prior to transfer of Trading Business from SBPL to Company, the Company had not commenced revenue-generating operations and did not have any income from operations.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Shankara Buildpro Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Shankara Buildpro Ltd is 2,127 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of November 1, 2026, the Shankara Buildpro Ltd stock price is INR ₹175.5. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Shankara Buildpro Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.